Jennifer Doudna facts for kids
Quick facts for kids
Jennifer Doudna
|
|
|---|---|
Doudna in 2023
|
|
| Born |
Jennifer Anne Doudna
February 19, 1964 Washington, D.C., U.S.
|
| Education |
|
| Known for |
|
| Spouse(s) |
Tom Griffin
(m. 1988, divorced)Jamie Cate
(m. 2000) |
| Awards |
|
| Scientific career | |
| Fields | Chemistry |
| Institutions | |
| Thesis | Towards the Design of an RNA Replicase (1989) |
| Doctoral advisor | Jack Szostak |
| Other academic advisors | Thomas Cech |
| Doctoral students |
|
Jennifer Anne Doudna is an American biochemist who helped create a groundbreaking tool for CRISPR gene editing. She won the 2020 Nobel Prize in Chemistry alongside French scientist Emmanuelle Charpentier. Together, they discovered how to rewrite the code of life using microscopic molecular tools. Doudna works as a professor at the University of California, Berkeley. She has also conducted research as an investigator with the Howard Hughes Medical Institute since 1997.
In 2012, Doudna and Charpentier showed that a bacterial defense system called CRISPR-Cas9 could act like programmable genetic scissors. This breakthrough became one of the greatest milestones in the history of biology. Scientists around the world now use this method of genome editing to fix damaged genes and study living things. Doudna continues to guide the global scientific community in using these powerful biological tools safely and fairly.
Contents
Early life and discovering a passion for nature
Jennifer Doudna was born on February 19, 1964, in Washington, D.C.. Her father earned his advanced degree from the University of Michigan and taught literature. Her mother held a master's degree in education and later taught history. When Jennifer was seven years old, her family moved to the tropical island town of Hilo, Hawaii. Her father took a teaching job in American literature at the University of Hawaii at Hilo.
Growing up in Hawaii, Jennifer fell in love with the vibrant plants and animals around her home. She explored lush rainforests, investigated exotic flowers, and observed curious sea creatures along the rocky beaches. Her parents filled their house with books about popular science, which fed her natural curiosity. When she was in the sixth grade, her father gave her a copy of The Double Helix. This book by James Watson told the exciting story of how scientists uncovered the double-spiral shape of DNA. Reading it made her realize that solving scientific mysteries was like cracking a secret code.
During her time at Hilo High School, Jennifer found great inspiration in her chemistry classes. Her tenth-grade teacher, Jeanette Wong, showed her that science was an active path of discovery rather than just memorizing facts. Hearing a guest scientist speak about human cells further convinced her that she wanted to study biology. During one summer vacation, she studied fungi in the laboratory of fungus expert Don Hemmes at the University of Hawaii at Hilo. She finished her high school studies in 1981, eager to learn more about the molecules that keep living things alive.
College education and early RNA research
Doudna attended Pomona College in Claremont, California, where she decided to study biochemistry. The demanding science courses were challenging, and she briefly thought about changing her studies to French. Her French teacher noticed her natural scientific talent and urged her to stick with chemistry. College professors such as Fred Grieman and Corwin Hansch provided wonderful encouragement and guidance. She performed her first serious experiments in the laboratory of Sharon Panasenko, earning her Bachelor of Arts degree in 1985.
To continue her training, Doudna entered Harvard Medical School in Massachusetts. She worked closely with geneticist Jack W. Szostak to explore how genetic molecules behave inside living cells. Her doctoral research focused on catalytic RNA, which are special molecules that can trigger chemical reactions. She finished her doctoral studies in 1989 after showing how certain RNA chains could copy themselves. Doudna then completed postdoctoral training at Massachusetts General Hospital and Harvard University.
From 1991 to 1994, Doudna continued her research at the University of Colorado Boulder alongside Nobel laureate Thomas Cech. She wanted to understand the three-dimensional structures of ribozymes, which are RNA molecules that act like an Enzyme. At the time, ribozymes were difficult to picture because their chemical shapes were too small for normal microscopes. Doudna used X-ray crystallography to map the shapes of these tiny biological catalysts.
Scientific discoveries and career milestones
In 1994, Doudna joined the faculty of Yale University as an assistant professor. Her research team focused on discovering the exact atomic shapes of large RNA molecules.
Uncovering the shapes of ribozymes
At Yale, Doudna's group succeeded in mapping the catalytic core of a Tetrahymena Group I ribozyme. They showed how magnesium ions gather in one area of the molecule to help it fold neatly into place. This shape allowed the RNA to speed up chemical reactions in ways scientists had previously seen only in a Protein. Her lab also mapped the shape of the Hepatitis Delta Virus ribozyme. These findings gave researchers fresh insight into cellular machinery, including the internal ribosome entry site and the signal recognition particle. In 2000, Yale promoted Doudna to the prestigious role of Henry Ford II Professor.
Moving research to UC Berkeley
In 2002, Doudna moved her research team to the University of California, Berkeley. She joined her husband, Jamie Cate, who was also a scientist working in the area. At Berkeley, she gained access to advanced equipment at the Lawrence Berkeley National Laboratory, including the powerful synchrotron beamline. This high-energy X-ray source let her team view the structures of complex biological molecules in sharp detail.
Doudna briefly worked for the biotechnology company Genentech in 2009 to direct new drug research. She soon realized that academic research was her true passion, so she returned to Berkeley with support from colleague Michael Marletta. Back in her university lab, she shifted her focus toward understanding how bacteria defend themselves against viral invaders.
The CRISPR-Cas9 genome editing revolution
In 2006, microbial researcher Jillian Banfield contacted Doudna to discuss repeating patterns found in bacterial DNA known as CRISPR. Years earlier, researchers such as Yoshizumi Ishino and Francisco Mojica noticed that bacteria stored snippets of DNA from viruses they had previously fought off. Bacteria used these saved snippets as a biological memory system to recognize returning enemies.
Doudna teamed up with French microbiologist Emmanuelle Charpentier to study the bacterial weapon called Cas9. Cas9 is a specialized protein that pairs with guide RNA to hunt down matching viral DNA. When the guide RNA spots the matching sequence, the Cas9 protein acts like sharp scissors and snips the viral DNA apart. In 2012, Doudna and Charpentier proved that humans could customize the guide RNA to target any piece of DNA they chose. This discovery allowed scientists to edit genes in living cells with incredible accuracy and speed.
Their breakthrough transformed laboratories worldwide. Scientists immediately started using CRISPR to study conditions like sickle cell anemia, cystic fibrosis, and Huntington's disease. Agricultural researchers also began using CRISPR to protect food crops against drought and disease. Along with student Samuel H. Sternberg, Doudna wrote the book A Crack in Creation to explain this amazing breakthrough to curious young readers and the general public.
Expanding biotechnology and medicine
Doudna has helped launch several research companies to turn genetic discoveries into helpful medicines. In 2011, she cofounded Caribou Biosciences, and she later helped start Intellia Therapeutics. She also co-founded Mammoth Biosciences in 2017 to create rapid diagnostic tests for human diseases, farming, and environmental health.
Doudna directs the Innovative Genomics Institute in California. This research center combines talent from UC Berkeley and the University of California, San Francisco to solve pressing problems in medicine and agriculture. She also holds the Li Ka Shing Chancellor's Professorship. In addition to editing animal and plant DNA, her laboratory studies ways to improve the beneficial bacteria living in human bodies, known as the microbiome.
Important questions about gene editing
Because CRISPR is so powerful, Doudna has taken a leading role in discussing how people should use it safely. She believes scientists must be open and honest about the potential dangers of altering living organisms. She helped organize international science conferences to discuss the rules of genetic medicine.
Doudna supports using gene editing to heal cells inside an individual sick patient, which is called somatic editing. These changes help cure illnesses without passing altered traits down to future generations. In contrast, she called for a global moratorium, or temporary pause, on editing reproductive cells, known as germline editing. Doudna reminds young scientists that having great power over biology requires deep responsibility, fairness, and care for all living things.
Personal life
While working on her research in Colorado, Doudna met fellow researcher Jamie Cate. The two scientists bonded over their shared love of laboratory experiments and married in Hawaii in 2000. When Doudna joined UC Berkeley, Cate joined the faculty as well. He studies how to improve yeast cells so they can make cleaner biofuels.
The couple raised their son in Berkeley, California. Doudna enjoys gardening, walking outside, and sharing the wonder of nature with students of all ages.
Major awards and honors
Doudna has earned many of the most famous prizes in modern science for her discoveries:
- Alan T. Waterman Award (2000), granted by the National Science Foundation to top young researchers.
- Breakthrough Prize in Life Sciences (2015), awarded with Emmanuelle Charpentier for developing CRISPR-Cas9 genome editing.
- Gruber Prize in Genetics (2015) and Canada Gairdner International Award (2016).
- Tang Prize (2016) and Japan Prize (2017) for life science breakthroughs.
- Kavli Prize in Nanoscience (2018), shared with Charpentier and Virginijus Šikšnys.
- Wolf Prize in Medicine (2020), celebrating medical advancements.
- Nobel Prize in Chemistry (2020), which she shared with Emmanuelle Charpentier for creating the CRISPR tool.
- National Inventors Hall of Fame induction (2023).
- National Medal of Technology and Innovation (2025).
- Priestley Medal (2026), the highest honor given by the American Chemical Society.
Doudna was elected to the National Academy of Sciences in 2002 and the American Academy of Arts and Sciences in 2003. She joined the National Academy of Medicine in 2010, the National Academy of Inventors in 2014, and the National Academy of Engineering in 2026. In 2016, she became a Foreign Member of the Royal Society in Great Britain. In 2021, Pope Francis appointed her to the Pontifical Academy of Sciences. Magazine editors named her to the Time 100 list of the world's most influential people, and she was a runner-up for Time Person of the Year in 2016. Her inspiring work shows how asking simple questions about nature can lead to discoveries that change the world.
See also
In Spanish: Jennifer Doudna para niños
